Harrow (HROW) Current Deferred Revenue (2017 - 2026)
Harrow (HROW) reported Current Deferred Revenue of $106,000 for Q2 2026, up 16.5% from $91,000 a year earlier but down 28.9% from the prior quarter.
Powered by 
Analysis
Harrow (HROW) Current Deferred Revenue (2017 - 2026) Analysis & Trends
At the end of FY2025, Harrow posted Current Deferred Revenue of $788,000.
- Current Deferred Revenue has a five-year compound annual growth rate of 64.2% (FY2020 to FY2025).
- By year, Current Deferred Revenue came in at $44,000 in FY2024 (-41.3%), $75,000 in FY2023 (-33.6%), $113,000 in FY2022 (+606.3%) and $16,000 in FY2021 (-75.8%).
- Five-year quarterly Current Deferred Revenue spans a low of $3,000 in Q3 2021 and a high of $788,000 in Q4 2025.
- Year over year, Current Deferred Revenue gained in four of the last seven quarters, with growth averaging 12.2%.
- The high point for year-over-year Current Deferred Revenue in five years was Q1 2022 (growth of 666.7%); the low point was Q3 2021 (a decline of 95.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $149,000 (Q1 2026), $788,000 (Q4 2025) and $345,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn |
| 10 | Harrow | 1.18 Bn | 850.90 Mn | 50.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 106,000.00 |
| Mar 31, 2026 | 149,000.00 |
| Dec 31, 2025 | 788,000.00 |
| Sep 30, 2025 | 345,000.00 |
| Jun 30, 2025 | 91,000.00 |
| Mar 31, 2025 | 145,000.00 |
| Dec 31, 2024 | 44,000.00 |
| Sep 30, 2024 | 137,000.00 |
| Jun 30, 2024 | 248,000.00 |
| Mar 31, 2024 | 112,000.00 |
| Dec 31, 2023 | 75,000.00 |
| Sep 30, 2023 | 153,000.00 |
| Jun 30, 2023 | 132,000.00 |
| Mar 31, 2023 | 67,000.00 |
| Dec 31, 2022 | 113,000.00 |
| Sep 30, 2022 | 115,000.00 |
| Jun 30, 2022 | 83,000.00 |
| Mar 31, 2022 | 23,000.00 |
| Dec 31, 2021 | 16,000.00 |
| Sep 30, 2021 | 3,000.00 |
API Access
Harrow Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=HROW&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "HROW", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=HROW&period=max&api_key=YOUR_API_KEY");
const data = await res.json();